NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
When Should You Visit a Neurologist? Recognizing Signs It’s Time for Expert Evaluation
As the body's command center, the brain and nervous system play a vital role in regulating various bodily functions, sensations, [...]
The Next Step in Alzheimer’s Care: The Potential of TMS Therapy in Cognitive Decline Management
Alzheimer's disease is a progressive neurological condition that affects millions of individuals worldwide, causing memory loss, cognitive decline, and impairment [...]
TMS Therapy: A Promising Frontier in Migraine Treatment and Prevention
Migraines affect millions of individuals worldwide, causing debilitating pain and disrupting daily activities. While traditional migraine treatments such as medication [...]
Breaking the Chains of OCD: TMS Therapy Offers New Hope for Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder (OCD) affects millions of individuals worldwide, creating significant challenges in their daily lives. While traditional treatments such as [...]
TMS Therapy Is Revolutionizing Neurological Care
As a leader in neurological innovation, Countryside Neurology is at the forefront of harnessing the power of TMS therapy to [...]
TMS Therapy Beyond Depression: Exploring its Impact on Anxiety and Stress Management
In today's fast-paced world, anxiety and stress have become prevalent challenges affecting millions. While TMS therapy has long been recognized [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social